Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
Hovione today announced the signing of a partnership agreement with Ligand to significantly ramp up the production output of Captisol®
C&EN, 21 November 2021
This certification is a recognition of Hovione´s resolve to put people first, and a validation that the investment in HR excellence is delivering.
Hovione is closer to its customers with a new website in Mandarin
Hovione reported today recent capacity expansion and future plans in its sites in Portugal, Ireland and New Jersey.
Silicon Republic, October 2, 2020
Pharmaceutical Technology, 2 Junho 2021
Hovione today announced the appointment of Dr. Jean-Luc Herbeaux as Hovione’s Chief Executive Officer, effective 1st April 2022
Hovione has completed significant expansions at its facilities in New Jersey, USA, and Cork, Ireland.
Google Chrome
Safari
Firefox
Edge